Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Edwards Lifesciences Corporation    EW

EDWARDS LIFESCIENCES CORPORATION

(EW)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/26/2021 03/01/2021 03/02/2021 03/03/2021 03/04/2021 Date
83.1(c) 85.77(c) 86.28(c) 84.25(c) 81.88(c) Last
2 641 873 3 184 609 3 315 772 2 514 292 2 764 010 Volume
-1.04% +3.21% +0.59% -2.35% -2.81% Change
More quotes
Financials (USD)
Sales 2021 5 054 M - -
Net income 2021 1 181 M - -
Net cash position 2021 1 413 M - -
P/E ratio 2021 42,6x
Yield 2021 -
Sales 2022 5 650 M - -
Net income 2022 1 386 M - -
Net cash position 2022 2 407 M - -
P/E ratio 2022 35,8x
Yield 2022 -
Capitalization 51 136 M 51 136 M -
EV / Sales 2021 9,84x
EV / Sales 2022 8,63x
Nbr of Employees 14 900
Free-Float 97,4%
More Financials
Company
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - hemodynamic monitoring systems (61.4%); - heart valves and surgery products (20.4%); - other (18.1%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the... 
More about the company
Notations Surperformance© of Edwards Lifesciences Corporation
Trading Rating : Investor Rating :
More Ratings
All news about EDWARDS LIFESCIENCES CORPORATION
02/12EDWARDS LIFESCIENCESá : Management's Discussion and Analysis of Financial Condit..
AQ
01/31EDWARDS LIFESCIENCESá : RESILIA Tissue Aortic Valve Demonstrates Favorable Safet..
PR
01/28EDWARDS LIFESCIENCESá : Oppenheimer Adjusts Price Target on Edwards Lifesciences..
MT
01/28EDWARDS LIFESCIENCESá : UBS Adjusts Price Target on Edwards Lifesciences to $91 ..
MT
01/27EDWARDS LIFESCIENCESá : Affirms 2021 Outlook
DJ
01/27EDWARDS LIFESCIENCESá : Profit, Revenue Grows
DJ
01/27EDWARDS LIFESCIENCESá : Posts Q4 Adjusted Profit of $0.50 Per Share, Up from $0...
MT
01/27EDWARDS LIFESCIENCES : 4Q Earnings Snapshot
AQ
01/27EDWARDS LIFESCIENCES CORPá : Results of Operations and Financial Condition, Fina..
AQ
01/27EDWARDS LIFESCIENCESá : Earnings Flash (EW) EDWARDS LIFESCIENCES CORPORATION Pos..
MT
01/27EDWARDS LIFESCIENCESá : Reports Fourth Quarter Results
PR
01/27EDWARDS LIFESCIENCESá : Earnings Flash (EW) EDWARDS LIFESCIENCES CORPORATION Pos..
MT
01/13EDWARDS LIFESCIENCESá : To Host Earnings Conference Call On January 27, 2021
PR
2020EDWARDS LIFESCIENCESá : Treats First Patient in Study Evaluating Device for Mitr..
MT
2020EDWARDS LIFESCIENCESá : Treats First Patient In U.S. Clinical Trial Evaluating M..
PR
More news
News in other languages on EDWARDS LIFESCIENCES CORPORATION
01/22EDWARDS LIFESCIENCES CORPORATIONá : Veröffentlichung des Jahresergebnisses
01/22EDWARDS LIFESCIENCES CORPORATIONá : publication des résultats annuels
2020EDWARDS LIFESCIENCES CORPORATIONá : Veröffentlichung des Quartalsergebnisses
2020EDWARDS LIFESCIENCES CORPORATIONá : publication des résultats trimestriels
2020EDWARDS LIFESCIENCES CORPORATIONá : Veröffentlichung des Halbjahresergebnisses
More news
Analyst Recommendations on EDWARDS LIFESCIENCES CORPORATION
More recommendations
Chart EDWARDS LIFESCIENCES CORPORATION
Duration : Period :
Edwards Lifesciences Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EDWARDS LIFESCIENCES CORPORATION
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 92,60 $
Last Close Price 81,88 $
Spread / Highest target 35,6%
Spread / Average Target 13,1%
Spread / Lowest Target -13,3%
EPS Revisions
Managers and Directors
NameTitle
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
Todd J. Brinton Chief Scientific Officer & VP-Advanced Technology
William J. Link Independent Director
Nicholas J. Valeriani Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
EDWARDS LIFESCIENCES CORPORATION-7.65%51 136
THERMO FISHER SCIENTIFIC-5.22%177 585
DANAHER CORPORATION-1.11%156 457
INTUITIVE SURGICAL, INC.-11.12%85 599
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.-9.54%76 083
ILLUMINA, INC.12.54%60 754